Combination lenalidomide-rituximab immunotherapy activates anti-tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma
Hsiling Chiu, Preeti Trisal, Chad Bjorklund, Soraya Carrancio, Estela G. Toraño, Carla Guarinos, Despoina Papazoglou, Patrick R. Hagner, Asma Beldi-Ferchiou, Karin Tarte, Marie-Hélène Delfau-Larue, Franck Morschhauser, Alan G. Ramsay, Anita K. Gandhi